Suppr超能文献

溴隐亭对犬的α-肾上腺素能阻断特性

Alpha-adrenolytic properties of bromocriptine in dogs.

作者信息

Montastruc J L, Montastruc P

出版信息

Arch Int Pharmacodyn Ther. 1982 Nov;260(1):83-90.

PMID:6131651
Abstract

The effects of bromocriptine on dose-response curves to intravenously administered sympathomimetic agents (adrenaline, noradrenaline, phenylephrine and clonidine) were studied in normotensive anesthetized dogs. After pretreatment with bromocriptine (0.3 or 1 mg/kg i.v.) low doses of adrenaline showed a significant depressor action. In contrast, this drug failed to modify the variations in blood pressure induced by noradrenaline. Bromocriptine reduced the pressor effect of phenylephrine and the hypotensive action of clonidine. These results suggest that, in addition to dopaminergic stimulant properties, bromocriptine also possesses alpha-adrenolytic properties. The data obtained with phenylephrine and clonidine suggest that bromocriptine is a mixed alpha 1 and alpha 2 antagonist. The differences observed between adrenaline and noradrenaline are discussed in term of different subtypes (intra- and extra-synaptic) of alpha-adrenoceptors.

摘要

在正常血压的麻醉犬中研究了溴隐亭对静脉注射拟交感神经药(肾上腺素、去甲肾上腺素、去氧肾上腺素和可乐定)剂量-反应曲线的影响。用溴隐亭(0.3或1mg/kg静脉注射)预处理后,低剂量肾上腺素显示出显著的降压作用。相反,该药物未能改变去甲肾上腺素引起的血压变化。溴隐亭降低了去氧肾上腺素的升压作用和可乐定的降压作用。这些结果表明,除了多巴胺能刺激特性外,溴隐亭还具有α-肾上腺素能阻断特性。用去氧肾上腺素和可乐定获得的数据表明,溴隐亭是一种混合的α1和α2拮抗剂。根据α-肾上腺素能受体的不同亚型(突触内和突触外)讨论了肾上腺素和去甲肾上腺素之间观察到的差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验